You haven't justified your claim that Investors could lose the LOT.
How is this likely?
Also thanks for misrepresenting my statements:
I didn't say Sirtex was exactly comparable, I used it as an example of how disappointing clinical trials will not necessarily result in delisting of the stock and shareholders losing everything.
Also Sirtex doesn't have a wide portfolio of patents, and a platform of multiple applications like MSB does.
BUT it is your claim that investors could lose the lot, and it's a timely exaggeration.
What is the likelihood of it happening? It's your claim not mine!
Justify it.
Trading high volume, page-125
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |